» Authors » Yejin Jang

Yejin Jang

Explore the profile of Yejin Jang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 255
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jung Y, Ahn S, An T, Cha H, Kim M, Cheon H, et al.
ACS Cent Sci . 2024 Sep; 10(8):1573-1584. PMID: 39220698
We present orally administrable prodrugs (s) of guanidino oseltamivir carboxylate () based on guanidine cyclic diimide (GCDI) to treat influenza viruses. By concealing the guanidine group, which significantly limits the...
2.
Seo Y, Jang Y, Lee S, Rhlee J, Kong S, Vo T, et al.
Exp Mol Med . 2024 Jul; 56(8):1736-1749. PMID: 39085352
The SARS-CoV-2 pandemic has had an unprecedented impact on global public health and the economy. Although vaccines and antivirals have provided effective protection and treatment, the development of new small...
3.
Shin J, Jang Y, Kim D, Jung E, Lee M, Kim B, et al.
Antimicrob Agents Chemother . 2024 May; 68(6):e0034124. PMID: 38742905
Cell culture-based screening of a chemical library identified diphenoxylate as an antiviral agent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The observed 50% effective concentrations ranged between 1.4 and...
4.
Jang Y, Nyamjav I, Kim H, Suh D, Park N, Lee Y, et al.
Sci Total Environ . 2024 Apr; 929:172775. PMID: 38670383
Environmental pollution caused by the excessive use of plastics has resulted in the inflow of microplastics into the human body. However, the effects of microplastics on the human gut microbiota...
5.
Kang K, Jang Y, Lee S, Jin M, Jun C, Kim M, et al.
Eur J Med Chem . 2023 Aug; 260:115720. PMID: 37633203
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M) has been targeted for the development of anti-SARS-CoV-2 agents against COVID-19 infection because M processes essential viral polyproteins and plays...
6.
Nyamjav I, Jang Y, Park N, Lee Y, Lee S
J Polym Environ . 2023 Jun; :1-14. PMID: 37361349
Supplementary Information: The online version contains supplementary material available at 10.1007/s10924-023-02878-y.
7.
Nyamjav I, Jang Y, Lee Y, Lee S
Front Microbiol . 2023 Jun; 14:1175249. PMID: 37260687
Polyvinyl chloride (PVC) is one of the widely used plastic products worldwide, and its accumulation in the natural environment has become a major global issue with regard to the environment...
8.
Son S, Ahn S, Kim G, Jang Y, Ko C, Kim M, et al.
Antiviral Res . 2023 Apr; 213:105591. PMID: 37003306
Influenza A virus continuously infects humans and the antigenic shifts of this respiratory virus enable it to cross the species barrier, threatening public health with the risk of pandemics. Broadly...
9.
Cha H, Kim U, Ahn S, Lee M, Lee H, Bang H, et al.
ACS Infect Dis . 2023 Mar; 9(4):1033-1045. PMID: 36912867
Gemcitabine is a nucleoside analogue of deoxycytidine and has been reported to be a broad-spectrum antiviral agent against both DNA and RNA viruses. Screening of a nucleos(t)ide analogue-focused library identified...
10.
An Y, Choi S, Choi E, Nam Y, Seo E, Ahn S, et al.
Bioorg Med Chem Lett . 2023 Feb; 83:129174. PMID: 36764470
Drug repurposing approach was applied to find a potent antiviral agent against RNA viruses such as SARS-CoV-2, influenza viruses and dengue virus with a concise strategy of small change in...